Injections vs Oral or Sublingual GLP-1: Which to Pick

Once you've chosen a molecule, the next fork is how you take it: a weekly injection or an oral/sublingual option. This isn't just a needle-versus-no-needle preference — the two formats differ in how much published evidence stands behind them. Here's a measured guide to picking the one that fits you.

Injections: the well-studied default

The large weight-loss trials everyone cites all studied once-weekly injections. Semaglutide reached about 15% average body-weight loss in STEP-1¹, tirzepatide hit the low-to-mid 20% range in SURMOUNT-1², and a head-to-head diabetes trial, SURPASS-2, compared the two injectables directly³. If you want the format with the strongest evidence base, injectable is the default. The downside is obvious — a weekly self-injection — but the needles are small, and most people adjust within a few weeks; see our injection guide for exactly where to inject and how to rotate sites once you've made the choice.

Oral and sublingual: convenience with a caveat

Oral tablets and sublingual (under-the-tongue) drops appeal to people who are needle-averse or want something simpler to travel with. Many well-run providers offer them. The honest caveat: most oral and sublingual GLP-1 options available through compounding pharmacies do not have the same large, published weight-loss trials behind them as the injectable products, and compounded medications are not FDA-approved products⁴. That doesn't make them a bad choice — it means you're trading some evidence certainty for convenience, so a transparent provider and clinician oversight matter even more.

How to weigh it

Pick injectable if you want the format with the deepest published evidence and don't mind a weekly shot. Lean oral or sublingual if needle aversion is a genuine barrier to starting or staying consistent — a slightly less-studied format you'll actually stick with can beat a well-studied one you avoid. Consistency is what drives results, so be honest with yourself about what you'll keep doing.

Which providers offer what

Most providers offer injectables; a smaller set adds oral or sublingual routes. Vaylen is notable for carrying injectable, oral, compounded, and brand in one place, so you can switch formats without switching providers. ShedRx is built around the oral/sublingual experience. The oral semaglutide tablet at MyDrHank is the unusual one: it is sold in a version compounded with low-dose ondansetron, aimed squarely at the nausea that ends a lot of titrations early. Three more are worth knowing about if the route is what decides it for you. SkinnyRx sells both molecules as a tablet as well as an injection, at the same price either way, so choosing the needle-free version costs nothing extra. Try Ageless prices its tirzepatide sublingual drops below either of its injections — $199 a month against $279 and $349 — and a clinician can move you between the three routes under the plan you already have. RxSpan MD carries oral capsules on both molecules alongside the injections and a brand-name lane, all on one storefront. In every case the caveat above still applies: the large published trials studied the injections. See the full breakdown of who offers oral options in our best GLP-1 provider by need guide, or line providers up in the comparison hub. For how the online providers rank on formulary and fit more broadly, see our factor-by-factor ranking.

Still deciding? Take the quiz

If format is your sticking point, the 2-minute quiz factors it in alongside budget and support, then reweights our honest Match Score to surface providers that carry the route you want. And if you haven't locked in a molecule yet, start with semaglutide vs tirzepatide — or browse the whole GLP-1 guide library.